Truist Securities adjusted their financial outlook for Axsome Therapeutics (NASDAQ:AXSM), increasing the price target to $190 from the previous $180 while maintaining a Buy rating on the company's ...

The super-regional bank plans to invest in talent, technology and certain locations in 2025, while keeping its expenses in check, to achieve the promise of the merger that created it, CEO Bill Rogers ...

Truist expects its expenses to fall by about 3 percent in the first quarter and increase roughly 1.5 percent for the full ...

Lesher also oversees Truist's corporate and investment banking arm, its commercial real estate group and its wealth division — three areas that Cummins had overseen before being named as COO. Cummins' ...

We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...

Leaders at the bank, which has been operating in DFW for more than a decade, want to capitalize on positive trends.

Truist analyst Michael Ciarmoli raised the firm’s price target on RBC Bearings (RBC) to $410 from $351 and keeps a Buy rating on the shares ...

Truist Financial (NYSE:TFC), the sixth largest U.S. commercial bank, reported fourth-quarter earnings on Friday, Jan. 17, that topped analyst consensus expectations. Adjusted diluted EPS of $0.91 ...

Lesher also oversees Truist's corporate and investment banking arm, its commercial real estate group and its wealth division — three areas that Cummins had overseen before being named as COO.

Truist Financial is a leading U.S. commercial bank with a significant presence in the Southeast and Mid-Atlantic regions. As a top-10 bank in the U.S., it benefits from a strong market position in ...